When patients self-administer their medications, 60% do not take them as intended and over half of all patients are non-adherent. The resulting cost of non-adherence and non-optimized therapy is steep and everyone pays the price. The rules around healthcare engagement are now being rewritten, and technology has the potential to augment patient care, deliver value across the digital health ecosystem, and deliver better outcomes for all stakeholders in a more connected future. Register now.
With patient care increasingly moving into outpatient facilities and even the home, auto-injectors are an increasingly viable option for enabling patients and their caregivers to self-administer therapies. However, there are a number of important considerations for pharmaceutical companies that are considering a move to auto-injector devices. Learn how product characteristics, formulation, and patient needs impact device selection and manufacturing processes – and how experienced partners can help. Download Now.
FDA is opening up to data gathered outside the hermetically sealed clinical trial setting as regulators recognize the need for a more flexible framework for evaluating treatments. As a new approach that requires significant investment, RWE use requires the right talent and technology. Where to find those resources and how to deploy them are some of the questions companies face. We’ll address these questions and more with the help of current practitioners in the field. Register now.
Interested in digitizing your R&D organization, but not sure where to start? Looking to move from a wealth of spreadsheets and outdated software systems into one centralized data repository? This webinar shows what a modern software system should look like for R&D and how that compares to how most companies operate today. Register Today!
UNITY Biotechnology partnered with Rho to execute a complex and fast-moving Osteoarthritis program with three concurrent clinical trials and database locks scheduled during the height of the COVID-19 pandemic. In this webinar, hear from both the Sponsor and CRO about the creative solutions they implemented and how they worked together to pivot quickly and meet critical study timelines in the midst of the pandemic. Register Now.
Learn actionable and real-world recommendations from Honeywell’s experienced ICS/OT cybersecurity team, as they reveal how they’ve coached both sites and enterprises to establish a resilient ICS/OT cybersecurity program. Register Now!
Learn how Eli Lily put the power of text mining in the hands of primary (non-data-scientist) users through Linguamatics Web Portals. With the on-going information explosion, natural language processing (NLP)-based text mining has become important to gain meaning effectively from unstructured text. Register now.
Life science technology leaders will discuss how Apprentice.io’s pharma-compliant remote collaboration platform helped them steady supply chains, better manage operations, and increase speed to market during the pandemic. Hear about how the adoption of this platform helped their teams successfully navigate manufacturing challenges and ultimately deliver safer, more reliable drug products, treatments and therapies – from COVID to cancer. Register now.
Learn how Prognos Health and Datavant are transforming & improving the way life sciences can access an extensive network of integrated real world data sources to define an ideal patient cohort as well as key demographic, therapeutic & customer insights. Register now.
This Fierce webinar will feature executives from leading biopharma companies and technology-development firms, who will describe the latest tools and techniques for improving biomarker discovery. They will discuss how they chose and deployed these technologies, provide examples of how they led to the discovery of novel biomarkers, and offer tips for selecting tools to aid in biomarker discovery and incorporating them into established R&D processes. Register Today!
This 77-page e-book explores 7 keys to success that any biopharma company needs to keep in mind as it enters Europe. This resource is helpful for companies that are considering a move into Europe, as well as those that are already present in Europe and working to maximize their opportunities there. Download now.
Learn which solutions manufacturers should consider from drug development through market maturity and when to start planning. Download the article.
Before 2020, web-based on-demand training was a novel concept used by only a few sponsors, and when the COVID-19 pandemic hit, web-based on-demand training became a necessity. Learn how combining on-demand training with web-based meetings has become the new best practice for clinical trials. Download now.
In this white paper you will learn how adopting a hybrid approach to engagement can create efficiency gains and enhance communications across a range of functions in life sciences. Learn more about the trend towards asynchronous (over-time) virtual engagement, the benefits of a hybrid virtual platform to improve communications and efficiency, and how various pharma functions are improving operations with a hybrid virtual approach. Download Now.
Sensors are transforming clinical trials by providing a 24/7 stream of objective insights into the health of patients. Sponsors, sites and most importantly patients all benefit from sensors, and use of the devices was on the rise even before COVID-19 turbocharged adoption. Yet, the nascent, fast-moving sensor sector poses challenges. Sponsors that navigate those challenges will be richly rewarded with clinical trials that generate new insights at record speeds. Download now.
Biotechnology companies of all sizes face many challenges in the development of new cell and gene therapies. In this webinar, Mike O’Mara and Dr. Ian Gaudet will introduce the development and manufacturing approach used by Miltenyi Biotec and describe how a CDMO partner focused in process and analytical development can enable clinical readiness. Register Now.
In 2020, consumers purchased over-the-counter (OTC) medicine heavily in March, but then shifted their consumption to vitamins and dietary supplements (VMS) for the remainder of the year. In this webinar, Catalent partnered with NielsenIQ to bring forward new insights that provide starting points for re-establishing growth via innovation in the OTC market. Save Your Spot - Register Now.
At each step in the product life cycle, pharma, biotech and medtech companies need to engage with third parties to develop, manufacture and sell their drugs, diagnostics and devices. With lives at stake and multiple players pursuing opportunities, companies that close deals quickly have a competitive edge. Yet, each contract exposes a company to an array of major third-party risks, creating a need for systems that support both speed and quality. Download this playbook to learn more.
Evolving R&D priorities and resource constraints across the globe mean clinical trials are more complex than ever. At the same time, COVID-19 has highlighted the urgent need for a more resilient and robust supply chain. Biopharma companies are heeding the call to innovate, be agile, reduce waste and, most of all, achieve patient-centricity. Flexible solutions like demand-led supply and direct-to-patient distribution are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies. Download to learn more.
Biopharma companies need to monitor for and report adverse events to ensure patient safety and remain in compliance. But an increase in adverse event reports is exposing a lack of coordination across adverse event data sources and shortcomings of manual, human-centered systems. Learn more!
Clinical trials can include an independent unbiased adjudication committee to evaluate the impact of clinical events on the overall study. Unfortunately, without the right approach to establishing a holistic clinical adjudication program, trial sponsors face issues with regulatory compliance, trial delays, and legal implications. Learn how evaluating people and technology against specific criteria can help you avoid costly risks and feel confident when selecting a partner for your program. Download Now.
Gain surprising insights from over 300 decision makers and influencers on how COVID-19 has impacted their CRO/CDMO outsourcing decisions in 2021 and beyond. How many are dissatisfied with their outsourcing provider? What percentage are looking for new CRO/CDMO partners within the next 12 months? Download the report.
Attend this webinar to learn about the role neutralising antibody testing plays in antibody detection, response to mass vaccination, longevity of immunity to SARS-CoV-2, and examine performance characteristics data. Register now.
COVID-19 has resulted in delayed care across specialties. Join us as we discuss returning to pre-pandemic clinical activity and strategies that biopharma organizations are using to engage HCPs. Register now.
With multiple COVID-19 vaccines approved and the rollout well underway, how can marketers best address misinformation, build trust, and win over the public? Get the latest insights into how you can use data, technology, and personalized messaging to build vaccine confidence and drive successful immunization efforts. Download the guide now.
As the field of protein therapeutics pushes into higher and higher concentration space, unique challenges that require creative solutions are becoming more evident. Drawing from a combined 40 years of biologics formulation experience, we have distilled key takeaways from high concentration development into this whitepaper. Download now.
Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM, a rare, life-threatening neuromuscular disease, affecting about 1 in 40-50,000 newborn males. The session will review how IPM.ia and Audentes collaborated to uncover the XLMTM patient population. Register now.
New research explores the impact of the COVID-19 pandemic on clinical trial management, including the acceleration of decentralized clinical trials. This report provides invaluable insight into the key challenges and opportunities surrounding these changes in this new environment. Download the report.
March Is Multiple Myeloma Month. In recognition of this important month, join us for a Precision Key Opinion Leader (KOL) Insights series webinar. You’ll hear from two leading investigators on the lessons learned, current trends, and insights relevant to the Multiple Myeloma (MM) US and EU research community. Dr. Paul Richardson and Dr. Maria-Victoria Mateos have collectively published >700 papers and both have been recognized for excellence in MM research. This is a rare opportunity to get a look into current MM treatment. Register Now.
The incorporation of patient-focused drug design principles early in the development cycle is critical to developing safe and effective treatments that address the specific needs of target patient populations in-terms of appropriateness, preference and usability. Download this webinar to discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes.
Patient-focused drug design can be a key factor in real-world therapeutic outcomes and business success. But if successful treatments should be created with patients in mind, when is the optimal time to solicit this feedback? And, what are the best methods for interacting with patients during drug development? This eBook features insights from experts in the industry on patient-centric drug development challenges and strategies on advancing drug design and development effectively. Download Now.
In this webinar, industry experts discuss the recent advances, challenges and considerations in pediatric drug development. Real-life examples presented by the experts illustrate the impact of age-appropriate dose forms for pediatrics and highlight insights into the caregiver perspectives. Watch the webinar to learn about a case study on real-world medications and acceptability assessment. Download Now.
Cell, gene-modified cell and gene therapies hold the promise to offer new hope and novel therapeutic avenues for individuals facing serious illnesses and medical conditions. But bringing these therapies successfully through the clinical trial process introduces a level of supply chain risk, complexity and specialized requirements which are not yet fully understood. This webinar focuses on taking a closer look at unique clinical supply challenges and unique needs associated with cell and gene therapies. Register Now.
Scaling up research procedures into clinical-scale manufacturing of new cellular therapeutics presents a challenge for many academic facilities. Join Drs. Adrian Gee and David McKenna in this live webinar for a discussion about the issues to be addressed when translating your cell and gene therapy research to the clinic; from picking your team to finding an effective culture system and beyond. Register Now.
The FDA has hired more than 50 new reviewers in anticipation of receiving 200 applications per year from companies hoping to start clinical trials of gene and cell therapies and issuing 10 to 20 new approvals a year by 2025. This webinar will review the latest developments in the regulatory review process for gene and cell therapies, offering advice that companies can use to streamline their interactions with regulators, both in the U.S. and overseas. Register Now.
Leaders discuss how Data Science as a Service (DSaaS) can empower life sciences organizations to tackle critical healthcare issues. Register now.
In this webinar, a panel of experts -- representing patient advocacy, cardiology, pharmaceutical, and health technology -- will discuss approaches for empowering individuals with heart conditions to act on best insights tailored to their specific situation (in a permissioned manner). Register Now.
Planning on using a CRO to support your next clinical study? Here are the top 9 questions you should always ask to help your CRO or partner of choice better understand your clinical supply needs. Download this Infographic to learn more.
Different clinical trials have different supply needs and strategies. Download this free Q&A article to learn about stability strategy for clinical trials, the importance of supply chain communication, automated control systems and country-specific labeling protocols.
Pharmaceutical companies face numerous hurdles during early development, from API manufacturing to drug product formulation to clinical supply logistics. Join Thermo Fisher Scientific experts to learn how a simplified supply chain may help increase efficiency and reduce risk as you move to your Phase I milestone. Register Now.
Accurate and timely delivery of clinical trial supplies helps to ensure that a study’s timeline stays on track. Sponsors often focus on upfront planning to ensure sites are prepared to reach clinical milestones but ignore the logistical challenges of reconciling and destroying clinical returns. Download this Article to learn about the top 3 clinical returns considerations for sponsors, how to anticipate requirements for clinical returns, and how country specific requirements can impact reverse logistics.
In this paper, Box will discuss how life sciences organizations can adapt to the new environment and propel therapies and medical devices through the value chain by rethinking content exchange. This paper will explain how cloud technologies accelerate the verification of documents and patient records at clinical trial sites, provide real-time access to regulated and non-regulated content, boost productivity and ensure GxP compliance to facilitate remote site monitoring. Download now.
The US FDA’s Breakthrough Therapy Designation, Regenerative Medicine Advanced Therapy Designation, Accelerated Approval Program, Priority Review, and Fast Track Designation can reduce your product’s development and approval timelines if pursued at the optimal time and implemented appropriately. Successfully navigate US FDA’s expedited programs for development of products for serious conditions: Understand the data expectations, planning and timing skills, and authoring strategies to optimize the chance of securing an expedited program designation. Register Now.
Cell and gene therapies are placing the patient at the center of the supply chain in a vastly new way, with implications for production, financial operations, product ordering, logistics and patient access and support. With these high-value therapies gaining more acclaim and moving from academic treatment centers to community care, their therapeutic and commercial success will be more highly scrutinized. Register Now!
Join LabCorp and Nutanix for this one-hour webinar to learn how cloud infrastructure technology platform is transforming the business. You will learn how a design partnership between LabCorp and Nutanix can have a long-lasting positive impact in elevating the role of IT teams to become the strategic business partners for the organization.
This webinar will focus on how a pharmacist-led clinical trial model impacts the six key areas most relevant to clinical trials in today’s COVID and Decentralized Clinical Trial environment: regulations, recruiting, diversity, clinical outcomes, data integrity, and clinical supply chain. Register Now.
Are you looking for a higher-quality, faster-time to market manufacturing solution for your protein therapeutic? Webinar attendees will learn how AbSci and KBI’s partnership enables cell line development through bulk microbial GMP manufacturing in 6 months, using cutting edge cell line development and biomanufacturing technology. Register Now.
Every year we ask our physicians their views on the future of the healthcare industry. With so much disruption from COVID-19, this year’s global insights will provide a unique window into the minds of those professionals perhaps most tested by 2020 and their hopes and perspectives for 2021. Register Now!
As modern life science R&D becomes more complex, variable, and fluid, organizations need informatics platforms that can keep up. Learn about the five essential capabilities of a life science R&D informatics platform in this whitepaper from Benchling. Download now.
The transition from early phase to late phase of a small molecule program plays a pivotal role in determining a program’s ultimate success. Join this webinar to hear experts discuss the key considerations for tech transfer and present how a customized modeling tool can help streamline the scale-up of your oral small molecule program. Register Now.
Along with the complexities of vaccine and viral-based gene therapy process development comes the need for analytical techniques that can help assess quality parameters, especially in real-time. Join Catalent and LumaCyte to learn how label-free analysis can provide near real-time infectivity measurements for vaccines and viral-based gene therapies. Register Today.
Rapid expansion of the gene and cell therapy pipeline created constraints to accessing contract capacities around the globe. Innovation in gene and cell therapy expanded many drug development pipelines, and startups that are lacking internal production capacities heavily rely on contract manufacturing organization (CDMO). Download this whitepaper to learn more.
Cell and gene therapies hold the promise to offer novel therapeutic avenues for individuals facing serious medical conditions, but bringing them through the clinical trial process introduces a level of supply chain risk and complexity. This survey focuses on unique clinical supply challenges and needs associated with cell and gene therapies. Take the survey now.
The covid vaccine launch has created a vast amount of calls to healthcare organizations. To keep up, you need a solution that can be stood up in less than 30 days. Join NeuraFlash & Salesforce as we showcase how to get started today! Register now.
How can health brands better connect with their audiences? Research insights determined four key factors. Verywell explains why they matter and how investing in them can pay off for both users and brands. Download the infographic to learn more.
Autologous cell therapies have seen propelled growth since 2017, with the spotlight on the first FDA approval of a chimeric antigen receptor (CAR) T cell immunotherapy, Kymriah® (tisagenlecleucel), for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia. While the first autologous cell therapy commercial products have shown tremendous clinical success, scaling out these therapies while considering individual patient processes is a new challenge. Download this eBrief to learn more.
Through this whitepaper, Samsung Biologics outlines the areas that were critical in adapting best practices for business management in dealing with the pandemic including employee safety, GMP compliance, supply chain management, and digital adaptation. Download now.
Digital Therapeutics are becoming increasingly important tools to drive meaningful improvements in patient outcomes and support the overall patient journey. Learn how life science organizations are leveraging cloud technology in the development and deployment of secure, low-latency digital therapeutic programs. Download the whitepaper.
One of the most critical elements in the quality control of pharmaceutical manufacturing is the use of lab balances and weighing equipment. When it comes to sample preparation and management, there is always the risk of error during measuring and weighing. Download the whitepaper to learn more.